Literature DB >> 23371042

International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia.

Mirjana Mitrovic1, Nada Suvajdzic, Andrija Bogdanovic, Nada Kraguljac Kurtovic, Aleksandra Sretenovic, Ivo Elezovic, Dragica Tomin.   

Abstract

High-hemorrhagic early death (ED) rate is a major impediment in the managing of acute promyelocytic leukemia (APL). In our group of 56 newly diagnosed APL patients, ED occurred in 12 subjects, due to endocranial bleeding (8/12), differentiation syndrome (2/12), or infection (2/12). Predictors of hemorrhagic ED were as follows: white blood cells count ≥ 20 × 10(9)/L (P = 0.002337), Eastern cooperative oncology group performance status ≥ 3 (P = 0.00173), fibrinogen level <2 g/L (P = 0.004907), prothrombin time <50% (P = 0.0124), and International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation (ISTH DIC score) ≥ 6 (P = 0.00741). Multivariate analysis indicated ISTH DIC score ≥ 6 to be the most significant predictor for hemorrhagic ED (P = 0.008). The main finding of this study is that simple coagulation-related tests, performed on hospital admission and combined in the ISTH DIC score, might help to identify patients at high risk for fatal bleeding needing more aggressive supportive measures.

Entities:  

Mesh:

Year:  2013        PMID: 23371042     DOI: 10.1007/s12032-013-0478-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  18 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy.

Authors:  Songul Serefhanoglu; Yahya Buyukasik; Hakan Goker; Nilgun Sayinalp; Ibrahim Celalettin Haznedaroglu; Salih Aksu; Osman Ilhami Ozcebe; Mehmet Turgut; Rahmi Aslan; Evren Ozdemir
Journal:  Leuk Res       Date:  2010-08-09       Impact factor: 3.156

Review 3.  Open issues on bleeding and thrombosis in acute promyelocytic leukemia.

Authors:  Miguel A Sanz; Pau Montesinos
Journal:  Thromb Res       Date:  2010-04       Impact factor: 3.944

4.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Authors:  Miguel A Sanz; Pau Montesinos; Chelo Rayón; Alexandra Holowiecka; Javier de la Serna; Gustavo Milone; Elena de Lisa; Salut Brunet; Vicente Rubio; José M Ribera; Concha Rivas; Isabel Krsnik; Juan Bergua; José González; Joaquín Díaz-Mediavilla; Rafael Rojas; Félix Manso; Gert Ossenkoppele; José D González; Bob Lowenberg
Journal:  Blood       Date:  2010-04-14       Impact factor: 22.113

6.  Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Authors:  Jae H Park; Baozhen Qiao; Katherine S Panageas; Maria J Schymura; Joseph G Jurcic; Todd L Rosenblat; Jessica K Altman; Dan Douer; Jacob M Rowe; Martin S Tallman
Journal:  Blood       Date:  2011-06-08       Impact factor: 22.113

7.  Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.

Authors:  Dae-Young Kim; Je-Hwan Lee; Jung-Hee Lee; Sung-Doo Kim; Sung-Nam Lim; Yunsuk Choi; Young-Shin Lee; Young-Ah Kang; Miee Seol; Mijin Jeon; Joo Youn Kim; Kyung-Hwa Lee; Yeon-Joo Lee; Kyoo-Hyung Lee
Journal:  Leuk Res       Date:  2010-06-15       Impact factor: 3.156

8.  Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.

Authors:  S Lehmann; A Ravn; L Carlsson; P Antunovic; S Deneberg; L Möllgård; A Rangert Derolf; D Stockelberg; U Tidefelt; A Wahlin; L Wennström; M Höglund; G Juliusson
Journal:  Leukemia       Date:  2011-04-19       Impact factor: 11.528

Review 9.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Authors:  J J van Dongen; E A Macintyre; J A Gabert; E Delabesse; V Rossi; G Saglio; E Gottardi; A Rambaldi; G Dotti; F Griesinger; A Parreira; P Gameiro; M G Diáz; M Malec; A W Langerak; J F San Miguel; A Biondi
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

Review 10.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Authors:  Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo-Coco
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

View more
  16 in total

1.  Is it all about cutoffs? Can DIC scores predict bleeding in APL?

Authors:  Hung Chang
Journal:  Med Oncol       Date:  2013-07-11       Impact factor: 3.064

2.  Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.

Authors:  Madhvi Rajpurkar; Todd A Alonzo; Yi-Cheng Wang; Robert B Gerbing; Alan S Gamis; James H Feusner; John Gregory; Matthew A Kutny
Journal:  J Pediatr Hematol Oncol       Date:  2019-01       Impact factor: 1.289

3.  Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.

Authors:  Tzu-Fei Wang; Robert S Makar; Darko Antic; Jerrold H Levy; James D Douketis; Jean M Connors; Marc Carrier; Jeffrey I Zwicker
Journal:  J Thromb Haemost       Date:  2020-12       Impact factor: 5.824

4.  Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centre.

Authors:  Farheen Karim; Usman Shaikh; Salman Naseem Adil; Mohammad Khurshid
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

5.  Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).

Authors:  Inaam Bashir Hassan; Mariam R Al Zaabi; Arif Alam; Mohammed Jawad Hashim; Martin S Tallman; Jorgen Kristensen
Journal:  Int J Hematol       Date:  2017-03-14       Impact factor: 2.490

6.  Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide.

Authors:  Yuan Wang; Wenyi Hou; Haitao Li; Xuanyu Tian; Jinqiao Li; Tianming Hu; Deli Shi; Yingmei Zhang
Journal:  Ann Hematol       Date:  2022-02-16       Impact factor: 3.673

7.  Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.

Authors:  Hitoshi Minamiguchi; Hiroyuki Fujita; Yoshiko Atsuta; Norio Asou; Toru Sakura; Yasunori Ueda; Masashi Sawa; Nobuaki Dobashi; Yasuhiro Taniguchi; Rikio Suzuki; Yoshihito Uchino; Akihiro Tomita; Shigehisa Tamaki; Maki Hagihara; Katsumichi Fujimaki; Masamitsu Yanada; Yoshinobu Maeda; Masako Iwanaga; Noriko Usui; Yukio Kobayashi; Shigeki Ohtake; Hitoshi Kiyoi; Itaru Matsumura; Yasushi Miyazaki; Tomoki Naoe; Akihiro Takeshita
Journal:  Ann Hematol       Date:  2020-09-02       Impact factor: 3.673

8.  Early death in acute promyelocytic leukemia: time to redefine risk groups.

Authors:  Meira Yisraeli Salman; Yishai Ofran
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047

9.  Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation.

Authors:  Michael Schwameis; Andreas Schober; Christian Schörgenhofer; Wolfgang Reinhard Sperr; Herbert Schöchl; Karin Janata-Schwatczek; Erol Istepan Kürkciyan; Fritz Sterz; Bernd Jilma
Journal:  Crit Care Med       Date:  2015-11       Impact factor: 7.598

10.  Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia.

Authors:  Yanru Pei; Mingyue Shi; Juanjuan Song; Xiaona Niu; Shengjie Wei; Liurui Dou; Mengyu Xiao; Dan Li; Fangfang Xu; Yanliang Bai; Kai Sun
Journal:  Cancer Manag Res       Date:  2021-05-21       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.